Question 1

Who owns AKTX?

Accepted Answer

Akari Therapeutics Plc (AKTX) is held by institutional investors who disclose positions via SEC 13F filings. View the full list of institutional holders on HoldingsIntel.

Question 2

Are institutions buying or selling AKTX?

Accepted Answer

HoldingsIntel tracks quarter-over-quarter changes in institutional positions for Akari Therapeutics Plc, showing new buyers, position increases, decreases, and exits with conviction-weighted sentiment.

Question 3

What is the Smart Money Verdict on AKTX?

Accepted Answer

The Smart Money Verdict combines four independent signals (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for Akari Therapeutics Plc.

Question 4

Is institutional money flowing into AKTX?

Accepted Answer

9 institutional investors hold Akari Therapeutics Plc (AKTX). View detailed buyer/seller breakdown on HoldingsIntel.

Question 5

What do hedge funds think about AKTX?

Accepted Answer

Track institutional sentiment and conviction scores for Akari Therapeutics Plc (AKTX) including Smart Money Verdict and position changes on HoldingsIntel.

Fund	Action	Shares	Value	Weight	Est. P&L	Conviction
Cresset Asset Management, LLC	Unchanged	822,468	$237,693	0.0%	-78.25%	0
HighTower Advisors, LLC	Unchanged	79,236	$22,899	0.0%	-80.17%	0
JANE STREET GROUP, LLC	New	71,644	$20,705	0.0%	-14.81%	29
XTX Topco Ltd	New	49,019	$14,166	0.0%	-14.81%	25
UBS Group AG	Increased	32,855(+547x)	$9,496	0.0%	-15.32%	19
Cerity Partners LLC	Unchanged	23,643	$6,833	0.0%	-93.03%	0
NewEdge Advisors, LLC	Unchanged	6,800	$1,965	0.0%	-80.17%	0
BANK OF AMERICA CORP /DE/	Increased	410(+173.3%)	$118	0.0%	-57.18%	12
MORGAN STANLEY	Unchanged	3	$1	0.0%	-91.67%	0
Virtu Financial LLC	Exited	0(-100.0%)	$22	0.0%	-73.53%	0

Akari Therapeutics Plc

Continue exploring